|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02197 CLOVER BIO-B
Nominal 
1.060 -0.080 (-7.018%) | 2022/12 - Final RMB(¥) | %Chg (Final to Final) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | |||
| Turnover | 0 | -- | 0 | 0 | 0 | ||
| Cost of Sales | -- | -- | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | -- | -- | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | ||
| Change in FV & Impairment on Others | -- | -- | (3,807,638,000) | (597,659,000) | 9,245,000 | ||
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | ||
| Other Non-operating Items | -- | -- | -- | -- | -- | ||
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | ||
| Profit / (Loss) before Taxation | (2,451,903,000) | -59.246% | (6,016,303,000) | (912,898,000) | (48,583,000) | ||
| Taxation | 0 | -- | 0 | 0 | 0 | ||
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | ||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | ||
| Others | -- | -- | -- | -- | -- | ||
| Profit / (Loss) Attributable to Shareholders | (2,451,903,000) | -59.246% | (6,016,303,000) | (912,898,000) | (48,583,000) | ||
| Net Finance Costs / (Income) | (2,577,000) | -3.628% | (2,674,000) | (435,000) | 9,549,000 | ||
| Depreciation & Amortisation | 58,080,000 | 180.431% | 20,711,000 | 5,784,000 | 2,397,000 | ||
| Directors' Emoluments | -- | -- | 24,784,000 | 7,307,000 | 3,023,000 | ||
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | ||
Market Valuation Indicators
| EPS (cts) | -222.000 | -- | -1,302.000 | -261.000 | -- | |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | |
| Cash flow per share ($) | -- | -- | -1.986 | 1.363 | -- | |
| NBV per share ($) | -0.517 | -- | 1.053 | -- | -- |
| Remarks: | Real time quote last updated: 08/06/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -2,451,903,000 |
| %Change | -59.246% |
| EPS / (LPS) | RMB -2.220 |
| NBV Per Share (¥) | RMB -0.517 |